DUBLIN, Calif., Sept. 11 SuperGen Inc.(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapiddevelopment and commercialization of therapies for solid tumors andhematological malignancies, today announced that James S. Manuso, Ph.D.,President and Chief Executive Officer is scheduled to present at theThinkEquity Annual Growth Conference on September 17, 2007, at the St. RegisHotel in San Francisco.
SuperGen's presentation at the ThinkEquity Annual Growth Conference isscheduled to begin at 10:30 a.m. PDT. A live webcast of the presentation willbe available on the investor relations section of the Company's Web site atwww.supergen.com. The webcast will be archived for 90 days.
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical companydedicated to the discovery, rapid development and commercialization oftherapies for solid tumors and hematological malignancies. SuperGen isdeveloping a number of therapeutic anticancer products focused on kinase andcell signaling inhibitors and DNA methyltransferase inhibitors. For moreinformation about SuperGen, please visit http://www.supergen.com.Contact: Timothy L. Enns Mary M. Vegh SuperGen, Inc. SuperGen, Inc. SVP, Corporate Communications Manager, Investor Relations & Business Development Tel: (925) 560-2845 Tel: (925) 560-0100 E-mail: email@example.com E-mail: firstname.lastname@example.org